In addition, Augustine today announced the founding of a Copenhagen, Denmark based subsidiary, Augustine Therapeutics Denmark ApS, which will serve as the company's hub for research related to ...

Juvenescence closes $76m first tranche of Series B-1 financing led by Abu Dhabi's M42 alongside strategic partnership Close of $76m Series B-1 tranche follows recent announcement of groundbreaking ...

Impaired neuromusculoskeletal function due to conditions such as stroke, osteoarthritis, cerebral palsy, Parkinson's disease, ...

Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that the ...